Febrile Neutropenia
Springer Berlin (Verlag)
978-3-540-61230-8 (ISBN)
High-Dose Chemotherapy: Safer and Better?.- Bone Marow Protectors in Cancer Treatment.- Hematopoietic growth factors in febrile neutropenia - Indications and limitations.- Incorporation of Quality-of-Life Considerations into Decisions Model for the Use of Colony-Stimulating Factors in Chemotherapy Patients at Risk for Febrile Neutropenia.- Assessing Risk in Cancer Patients with Fever and Neutropenia.- Therapeutic Approach in the Ambulatory Setting, Feasability and Surveillance.- The Sequence of Infective Events in Prolonged Neutropenia.- The Empirical Therapeutic Cascade: When to Start and When to Stop?.- Treatment of Neutropenic Infection: Trends Towards Monotherapy?.- The Changing Spectrum of Bacterial Infections in Febrile Neutropenic Patients.- Susceptibility of Streptococci Isolated from Blood of Neutropenic Patients to 11 Antibiotics.- Emerging Antibiotic Resistance in bacterial Pathogens.- Cefepime Versus Ceftazidime as Empiric Therapy of Febrile Episodes in Neutropenic Patients.- Cefepime Versus Ceftazidime in the Empiric Treatment of Febrile Neutropenic Children with Malignancy.- Cefepime-Vancomycin Versus Ceftazidime-Vancomycin as Empiric Therapy in Febrile Neutropenic Patients.- Monotherapy with Meropenem Versus Combination Therapy with Ceftazidime Plus Amikacin as Empiric Therapy for Fever in Granulocytopenic Patients with Cancer.- Piperacillin plus Tazobactam Versus Ceftazidime plus Amikacin in Febrile Neutropenia: A Comparison in Terms of Cost and Efficacy.- Fungal Infection in Neutropenic Patients: Past Achivements and Future Problems.- The Pressure of Emerging Resistance in Fungal Diseases.- Liposomal Versus Conventional Amphotericin B for the Treatment of Fever of Unknown Origin in Neutropenic Patients: Results of two Randomized Trials in 204 Childrenand 134 Adults.- Pulmonary Infiltrate Etiology in Leukemic Patients with Fever.- Marrow Transplantation: Current Results and Effect of Immunoglobulin Prophylaxis.- The Role of Economic Evaluation in Assessing the Cost of Febrile Neutropenia.- Quality of life in Patients with Febrile Neutropenia.
Erscheint lt. Verlag | 6.12.1996 |
---|---|
Zusatzinfo | XVI, 130 p. 4 illus. |
Verlagsort | Berlin |
Sprache | englisch |
Maße | 155 x 235 mm |
Gewicht | 245 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pädiatrie | |
Schlagworte | Antibiotics • Blood • Cancer Treatment • Chemotherapy • growth • Morbidity • Mortality • prevention • Transplantation |
ISBN-10 | 3-540-61230-0 / 3540612300 |
ISBN-13 | 978-3-540-61230-8 / 9783540612308 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich